In the GBM microenvironment, oncostatin M (OSM) derived from tumor‐associated macrophages (GAMs) activates STAT3 by binding to the OSMR/LIFR–GP130 receptor complex, driving mesenchymal transition of GBM cells [486]. The gene discussed is LIFR; the disease is glioblastoma.